Assessing and managing frailty in advanced heart failure: An International Society for Heart and Lung Transplantation consensus statement.

frailty heart failure heart transplantation mechanical circulatory support

Journal

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
ISSN: 1557-3117
Titre abrégé: J Heart Lung Transplant
Pays: United States
ID NLM: 9102703

Informations de publication

Date de publication:
29 Nov 2023
Historique:
received: 22 09 2023
accepted: 25 09 2023
medline: 15 12 2023
pubmed: 15 12 2023
entrez: 15 12 2023
Statut: aheadofprint

Résumé

Frailty is increasingly recognized as a salient condition in patients with heart failure (HF) as previous studies have determined that frailty is highly prevalent and prognostically significant, particularly in those with advanced HF. Definitions of frailty have included a variety of domains, including physical performance, sarcopenia, disability, comorbidity, and cognitive and psychological impairments, many of which are common in advanced HF. Multiple groups have recently recommended incorporating frailty assessments into clinical practice and research studies, indicating the need to standardize the definition and measurement of frailty in advanced HF. Therefore, the purpose of this consensus statement is to provide an integrated perspective on the definition of frailty in advanced HF and to generate a consensus on how to assess and manage frailty. We convened a group of HF clinicians and researchers who have expertise in frailty and related geriatric conditions in HF, and we focused on the patient with advanced HF. Herein, we provide an overview of frailty and how it has been applied in advanced HF (including potential mechanisms), present a definition of frailty, generate suggested assessments of frailty, provide guidance to differentiate frailty and related terms, and describe the assessment and management in advanced HF, including with surgical and nonsurgical interventions. We conclude by outlining critical evidence gaps, areas for future research, and clinical implementation.

Identifiants

pubmed: 38099896
pii: S1053-2498(23)02028-4
doi: 10.1016/j.healun.2023.09.013
pii:
doi:

Types de publication

Practice Guideline

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2023 International Society for the Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

Auteurs

Quin E Denfeld (QE)

School of Nursing, Oregon Health & Science University, Portland, Oregon; Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon. Electronic address: denfeldq@ohsu.edu.

Sunita R Jha (SR)

Faculty of Medicine, University of Notre Dame, Sydney, Australia.

Erik Fung (E)

Division of Cardiology and Gerald Choa Cardiac Research Centre, Department of Medicine & Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China; Laboratory for Heart Failure + Circulation Research, Li Ka Shing Institute of Health Sciences, Prince of Wales Hospital, Hong Kong SAR, China; CUHK Medical Centre, Hong Kong and CUHK-Shenzhen School of Medicine, Shenzhen, China.

Tiny Jaarsma (T)

Department of Medicine, Health and Caring Sciences, Linköping University, Linköping, Sweden; Department of Nursing Science, Julius Center, University Medical Center Utrecht, Utrecht, the Netherlands.

Mathew S Maurer (MS)

Columbia University Irving Medical Center, New York, New York.

Gordon R Reeves (GR)

Section on Cardiovascular Medicine, School of Medicine, Wake Forest University, Winston-Salem, North Carolina.

Jonathan Afilalo (J)

Division of Cardiology, Jewish General Hospital, McGill University, Montreal, Quebec, Canada; McGill University, Montreal, Quebec, Canada.

Nadine Beerli (N)

Nursing Science, Department Public Health, University of Basel, Basel, Switzerland.

Lavanya Bellumkonda (L)

Section of Cardiovascular Medicine, Department of Medicine, Yale School of Medicine, New Haven, Connecticut.

Sabina De Geest (S)

Nursing Science, Department Public Health, University of Basel, Basel, Switzerland; Academic Center of Nursing and Midwifery, Department Public Health and Primary Care, KU Leuven, Belgium.

Eiran Z Gorodeski (EZ)

Harrington Heart & Vascular Institute, University Hospitals Cleveland Medical Center, Cleveland, Ohio; Case Western Reserve University School of Medicine, Cleveland, Ohio.

Emer Joyce (E)

Department of Cardiology, Mater University Hospital, Dublin, Ireland; School of Medicine, University College Dublin, Dublin, Ireland.

Jon Kobashigawa (J)

Cedars Sinai Medical Center, Los Angeles, California.

Oliver Mauthner (O)

Nursing Science, Department Public Health, University of Basel, Basel, Switzerland.

Julee McDonagh (J)

School of Nursing, Faculty of Science, Medicine and Health, University of Wollongong, New South Wales, Australia; The Centre for Chronic and Complex Care Research, Blacktown Hospital, Western Sydney Local Health District, New South Wales, Australia.

Izabella Uchmanowicz (I)

Department of Clinical Nursing, Faculty of Health Sciences, Wroclaw Medical University, Wroclaw, Poland.

Victoria Vaughan Dickson (VV)

School of Nursing, University of Connecticut, Storrs, Connecticut.

JoAnn Lindenfeld (J)

Vanderbilt Heart and Vascular Institute, Nashville, Tennessee.

Peter Macdonald (P)

St Vincent's Hospital, Sydney, Australia; Victor Chang Cardiac Research Institute, Sydney, Australia; University of New South Wales, Sydney, Australia.

Classifications MeSH